Literature DB >> 35584830

How to approach haemolysis: Haemolytic anaemia for the general physician.

David Palmer1, Dale Seviar2.   

Abstract

Haemolytic anaemia can seem like a complicated topic. The constellation of reticulocytosis, increased lactate dehydrogenase levels, increased unconjugated bilirubin levels and decreased haptoglobin levels should prompt general physicians to consider haemolysis as a differential diagnosis. When further approaching haemolytic anaemia, subdividing patients into those who are 'direct antiglobulin test (DAT) positive' (immune) or 'DAT negative' (non-immune) is a simple and clinically relevant way to start to formulate a cause for the haemolytic anaemia. Immune causes of haemolytic anaemia include autoimmune haemolytic anaemia, drugs and delayed haemolytic transfusion reactions. Non-immune causes include the haemoglobinopathies (such as sickle cell disease) and microangiopathic haemolytic anaemias (such as disseminated intravascular coagulation). Early supportive care in haemolytic anaemia is important and may involve blood transfusions as well as interventions to slow the rate of haemolysis, such as steroids in autoimmune haemolytic anaemia. Complications of haemolysis include pigment gallstones, high-output cardiac failure and thromboembolism. Haemolytic anaemia should be referred to the haematologist for further investigation, however, the recognition and early management by the general physician is imperative in improving the patient's outcome. © Royal College of Physicians 2022. All rights reserved.

Entities:  

Keywords:  anaemia; autoimmune haemolytic anaemia; direct antiglobulin test; haemolysis

Mesh:

Year:  2022        PMID: 35584830      PMCID: PMC9135086          DOI: 10.7861/clinmed.2022-0142

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN: 1470-2118            Impact factor:   5.410


  8 in total

1.  Guidelines on the management of drug-induced immune and secondary autoimmune, haemolytic anaemia.

Authors:  Quentin A Hill; Robert Stamps; Edwin Massey; John D Grainger; Drew Provan; Anita Hill
Journal:  Br J Haematol       Date:  2017-04-03       Impact factor: 6.998

2.  The diagnosis and management of primary autoimmune haemolytic anaemia.

Authors:  Quentin A Hill; Robert Stamps; Edwin Massey; John D Grainger; Drew Provan; Anita Hill
Journal:  Br J Haematol       Date:  2016-12-22       Impact factor: 6.998

Review 3.  The Direct Antiglobulin Test: Indications, Interpretation, and Pitfalls.

Authors:  Victoria Parker; Christopher A Tormey
Journal:  Arch Pathol Lab Med       Date:  2017-02       Impact factor: 5.534

4.  Guidelines for the diagnosis and management of hereditary spherocytosis--2011 update.

Authors:  Paula H B Bolton-Maggs; Jacob C Langer; Achille Iolascon; Paul Tittensor; May-Jean King
Journal:  Br J Haematol       Date:  2011-11-05       Impact factor: 6.998

Review 5.  Auto-immune haemolytic anaemia--a high-risk disorder for thromboembolism?

Authors:  A M Hendrick
Journal:  Hematology       Date:  2003-02       Impact factor: 2.269

6.  Foot-strike haemolysis in an ultramarathon runner.

Authors:  Abid A Fazal; Mary S Whittemore; Katharine C DeGeorge
Journal:  BMJ Case Rep       Date:  2017-12-13

Review 7.  Autoimmune hemolytic anemia.

Authors:  Bradley C Gehrs; Richard C Friedberg
Journal:  Am J Hematol       Date:  2002-04       Impact factor: 10.047

Review 8.  Advances in the management of TTP.

Authors:  M Subhan; M Scully
Journal:  Blood Rev       Date:  2022-02-17       Impact factor: 10.626

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.